Quantinno Capital Management LP Uro Gen Pharma Ltd. Transaction History
Quantinno Capital Management LP
- $35.1 Billion
- Q3 2025
A detailed history of Quantinno Capital Management LP transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Quantinno Capital Management LP holds 20,309 shares of URGN stock, worth $494,117. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,309
Previous 21,073
3.63%
Holding current value
$494,117
Previous $288,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding URGN
# of Institutions
171Shares Held
43.8MCall Options Held
1.61MPut Options Held
433K-
Rtw Investments, LP New York, NY4.54MShares$111 Million1.19% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.22MShares$103 Million2.65% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.19MShares$77.6 Million0.1% of portfolio
-
Morgan Stanley New York, NY2.53MShares$61.5 Million0.0% of portfolio
-
Jefferies Financial Group Inc. New York, NY2.2MShares$53.5 Million0.21% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $553M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...